INTRODUCTION: The indications for a total pancreatectomy (TP), its peri-operative management, provision of pancreatic surgical services and medical treatment of the inherent exo- and endocrine deficient states have all changed considerably over recent decades. The effects of these upon the incidence, indications for and outcomes of TP are unclear. Patients undergoing TP at a single institution over a quarter of a century were reviewed to try to address these issues. METHODS: Data on patients who underwent elective (el-) and emergency TP (em-TP) between 1987 and 2013 were reviewed. Patient demographics, indications, intra-operative details, peri-operative management and long-term outcomes were analysed. Absolute numbers of TP were reported relative to partial pancreatectomy rates. RESULTS: In total, 136 patients underwent TP [98 (72.1%) el-TP; 38 (27.9%) em-TP]. There was a significant change in indication for el-TP with it increasingly performed for (an intraductal papillary mucinous neoplasm (IPMN) and renal cell metastases whereas there was a decrease in the number of el-TP performed for chronic pancreatitis (P = 0.025). The relative rates of el-TP, however, did not change significantly across the study period (P = 0.225). The median length of stay after el-TP decreased from 19 days pre-1997 to 12 days post-1997 (P = 0.009). The relative use of em-TP declined by 0.28 percentage points per year [P = 0.018; 95% confidence interval (CI): 0.04-0.41]. CONCLUSIONS: The indications for el-TP have changed; it is being performed more frequently although the proportion relative to other pancreatic resections has not changed. A decrease in the rate of em-TP is likely to reflect improved peri-operative management of a pancreatic fistula and its complications after a pancreaticoduodenectomy.
INTRODUCTION: The indications for a total pancreatectomy (TP), its peri-operative management, provision of pancreatic surgical services and medical treatment of the inherent exo- and endocrine deficient states have all changed considerably over recent decades. The effects of these upon the incidence, indications for and outcomes of TP are unclear. Patients undergoing TP at a single institution over a quarter of a century were reviewed to try to address these issues. METHODS: Data on patients who underwent elective (el-) and emergency TP (em-TP) between 1987 and 2013 were reviewed. Patient demographics, indications, intra-operative details, peri-operative management and long-term outcomes were analysed. Absolute numbers of TP were reported relative to partial pancreatectomy rates. RESULTS: In total, 136 patients underwent TP [98 (72.1%) el-TP; 38 (27.9%) em-TP]. There was a significant change in indication for el-TP with it increasingly performed for (an intraductal papillary mucinous neoplasm (IPMN) and renal cell metastases whereas there was a decrease in the number of el-TP performed for chronic pancreatitis (P = 0.025). The relative rates of el-TP, however, did not change significantly across the study period (P = 0.225). The median length of stay after el-TP decreased from 19 days pre-1997 to 12 days post-1997 (P = 0.009). The relative use of em-TP declined by 0.28 percentage points per year [P = 0.018; 95% confidence interval (CI): 0.04-0.41]. CONCLUSIONS: The indications for el-TP have changed; it is being performed more frequently although the proportion relative to other pancreatic resections has not changed. A decrease in the rate of em-TP is likely to reflect improved peri-operative management of a pancreatic fistula and its complications after a pancreaticoduodenectomy.
Authors: Brian J Billings; John D Christein; William S Harmsen; Jeffrey R Harrington; Suresh T Chari; Florencia G Que; Michael B Farnell; David M Nagorney; Michael G Sarr Journal: J Gastrointest Surg Date: 2005-11 Impact factor: 3.452
Authors: C Max Schmidt; Jeffrey Glant; Jordan M Winter; Jason Kennard; Jennifer Dixon; Qianqian Zhao; Thomas J Howard; James A Madura; Atilla Nakeeb; Henry A Pitt; John L Cameron; Charles J Yeo; Keith D Lillemoe Journal: Surgery Date: 2007-10 Impact factor: 3.982
Authors: John A Stauffer; Justin H Nguyen; Michael G Heckman; Manpreet S Grewal; Marjorie Dougherty; Kanwar R S Gill; Laith H Jamil; Daniela Scimeca; Massimo Raimondo; C Daniel Smith; J Kirk Martin; Horacio J Asbun Journal: HPB (Oxford) Date: 2009-09 Impact factor: 3.647
Authors: Melissa M Murphy; William J Knaus; Sing Chau Ng; Joshua S Hill; James T McPhee; Shimul A Shah; Jennifer F Tseng Journal: HPB (Oxford) Date: 2009-09 Impact factor: 3.647
Authors: Michael W Müller; Helmut Friess; Jörg Kleeff; Rolf Dahmen; Markus Wagner; Ulf Hinz; Daniela Breisch-Girbig; Güralp O Ceyhan; Markus W Büchler Journal: Ann Surg Date: 2007-12 Impact factor: 12.969
Authors: Riccardo Casadei; Claudio Ricci; Giovanni Taffurelli; Anna Guariniello; Anthony Di Gioia; Mariacristina Di Marco; Nico Pagano; Carla Serra; Lucia Calculli; Donatella Santini; Francesco Minni Journal: J Gastrointest Surg Date: 2016-07-14 Impact factor: 3.452
Authors: Lapo Bencini; Mario Annecchiarico; Marco Farsi; Ilenia Bartolini; Vita Mirasolo; Francesco Guerra; Andrea Coratti Journal: World J Gastrointest Oncol Date: 2015-12-15
Authors: Wenchuan Wu; Rebecca Dodson; Martin A Makary; Matthew J Weiss; Kenzo Hirose; John L Cameron; Nita Ahuja; Timothy M Pawlik; Christopher L Wolfgang; Jin He Journal: World J Surg Date: 2016-10 Impact factor: 3.352
Authors: Hazem M Zakaria; John A Stauffer; Massimo Raimondo; Timothy A Woodward; Michael B Wallace; Horacio J Asbun Journal: World J Gastrointest Surg Date: 2016-09-27
Authors: L Scholten; T F Stoop; M Del Chiaro; O R Busch; C van Eijck; I Q Molenaar; J H de Vries; M G Besselink Journal: Br J Surg Date: 2019-09-10 Impact factor: 6.939